1 |
Finn WF, Joy MS, Hladik G. Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis. Clin Nephrol 2004;62:193-201
DOI
PUBMED
ScienceOn
|
2 |
Yorgin PD, Al-Uzri A. Management of renal anemia. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. Boston: Kluwer academic publishers, 2004
|
3 |
Samuels JA, Sorof JM. Blood pressure management in the dialysis patient. Boston: Kluwer academic publishers, 2004
|
4 |
Neu AM, Fivush BA. Immunizations for pediatric dialysis patients. Adv Ren Replace Ther 2000;7:239-46
DOI
ScienceOn
|
5 |
National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 2009;53:S11-104
|
6 |
Mahan JD, Patel HP. Recent advances in pediatric dialysis: a review of selected articles. Pediatr Nephrol 2008;23:1737-47
DOI
ScienceOn
|
7 |
McSherry E, Morris RC, Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 1978;61:509-27
DOI
|
8 |
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201
|
9 |
Seeherunvong W, Nwobi O, Abitbol CL, Chandar J, Strauss J, Zilleruelo G. Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol 2006;21:1434-9
DOI
ScienceOn
|
10 |
Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, Sawyers ES, et al. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 2007;49:801-13
DOI
ScienceOn
|
11 |
Rastogi A, Macdoougall IC, Nissenson AR. Anemia in PD patients. In: Khanna R, Krediet RT, editors. Nolph and Gokal's textbook of peritoneal dialysis. 3rd ed. Missouri: Springer Science, 2009:713-36
|
12 |
Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996;11:813-9
DOI
ScienceOn
|
13 |
Goldsmith DR, Scott LJ, Cvetkovic RS, Plosker GL. Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis. Drugs 2008;68:85-104
DOI
ScienceOn
|
14 |
Amaral S, Hwang W, Fivush B, Neu A, Frankenfield D, Furth S. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis. J Am Soc Nephrol 2006;17:2878-85
DOI
ScienceOn
|
15 |
Secker D. Achieving nutritional goals for children on dialysis. In: Warady BA, Schaefer FS, Fine RN, Alexander SR, editors. Pediatric dialysis. 1st ed. Boston: Kluwer Academic Publishers, 2004:221-42
|
16 |
Macdougall IC, Roberts DE, Coles GA, Williams JD. Clinical pharmacokinetics of epoetin (recombinant human erythropoietin). Clin Pharmacokinet 1991;20:99-113
DOI
ScienceOn
|
17 |
Evenepoel P, Selgas R, Caputo F, Foggensteiner L, Heaf JG, Ortiz A, et al. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis. Nephrol Dial Transplant 2009;24:278-85
DOI
ScienceOn
|
18 |
National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007;50:471-530
DOI
ScienceOn
|
19 |
Vogt BA, Avner ED. Renal failure. In: Kliegman RM, Behrman RE, Jenson HB, F. SB, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders, 2007:2206-14
|
20 |
Fine RN, Kohaut EC, Brown D, Perlman AJ. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr 1994;124:374-82
DOI
ScienceOn
|
21 |
Bernstein D. Diseases of the peripheral vascular system. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders, 2007:1988-9
|
22 |
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266
DOI
ScienceOn
|
23 |
National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S1-290
|
24 |
Sadowski RH, Falkner B. Hypertension in pediatric patients. Am J Kidney Dis 1996;27:305-15
DOI
ScienceOn
|
25 |
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005;46:S1-121
|
26 |
Drueke TB, Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 2009;4:234-41
DOI
ScienceOn
|